Key result
Positive dynamic hyperinflation in stable asthma linked to ~19% higher serum periostin levels.
Why the study?
Dynamic hyperinflation is associated with impaired daily life activities in asthma, but its relationship with asthma biomarkers such as blood eosinophils, FeNO, and serum periostin was unclear.
Does serum periostin correlate with dynamic hyperinflation in patients with stable asthma?
Observational (n=50)
Does serum periostin correlate with dynamic hyperinflation in patients with stable asthma?
Serum periostin levels correlate with dynamic hyperinflation in stable asthma, suggesting it may serve as a useful biomarker for assessing this condition.
Answers are grounded in this paper and cite their sources.
Suggests periostin as potential biomarker for dynamic hyperinflation in stable asthma; hypothesis-generating and needs prospective validation.
Introduction Dynamic hyperinflation (DH) is sometimes observed and is associated with impaired daily life activities of asthma. We assessed the relationship between DH and asthma biomarkers (blood eosinophil, fractional exhaled nitric oxide (FeNO) and serum periostin) in patients with asthma. Methods Fifty patients with stable asthma were prospectively recruited and underwent blood test,FeNOmeasurement, spirometry and metronome-paced tachypnoea (MPT) test to assess DH. In MPT tests, inspiratory capacity (IC) was measured at baseline and after 30 s of MPT with breathing frequencies of 20, 30 and 40 breaths·min−1. DH was assessed by the decline of IC from baseline, and maximal IC reduction ≥10% was considered as positive DH. Results Thirty patients (60%) showed positive DH. Patients with positive DH showed higher serum periostin levels (107.0±30.7 ng·mL−1) than patients with negative DH (89.7±23.7) (p=0.04). Patients in Global Initiative for Asthma treatment steps 4–5 (n=19) showed higher serum periostin levels (p=0.01) and more severe IC reduction after MPT (p<0.0001) than patients in steps 1–3 (n=31). Maximal IC reduction after MPT was significantly correlated with asthma control test score (r=−0.28, p=0.05), forced expiratory volume in 1 s (r=−0.56, p<0.0001), and serum periostin levels (r=0.41, p=0.003). Conclusion Serum periostin may have the possibility to reflect DH in patients with stable asthma.
No takes yet. Share an insight, caveat, or question.
Asano et al. (2020) conducted an observational in Asthma (n=50). Positive dynamic hyperinflation vs. Negative dynamic hyperinflation was evaluated on Serum periostin levels (p=0.04). Positive dynamic hyperinflation in stable asthma patients was associated with higher serum periostin levels compared to those without.
Synapse has enriched 10 related papers. Consider them for comparative context: